88.15 USD
↘ 0.90 (1.01%)AT CLOSE (03:59 PM EDT)
Abivax SA American Depositary Shares
ABVXNASDAQ • USD
88.09
↘ 0.07 (0.07%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
88.09
↘ 0.07 (0.07%)
Market: CLOSED
ABVX is currently priced at $88.15. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 9, 2026.
Open?$90.21
High?$90.56
Low?$87.39
Prev. Close?$89.05
Volume?885.3K
Avg. Volume?N/A
VWAP?$88.65
Bid / Ask
Bid?$87.50 × 100
Ask?$88.99 × 200
Spread?$1.49
Midpoint?$88.25
Valuation & Ratios
Market Cap?7.7B
Shares Out?87.4M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short Interest?7.8M
Days to Cover?5.1
Avg Daily Volume1.5M
Settlement Date2026-09-30